Glass House Brands (GLAS) Minority Interest (2020 - 2026)
Glass House Brands' (GLAS) quarterly Minority Interest came in at $8.1 million in Q1 2026, up 118.76% year-on-year from $3.7 million in Q1 2025, and down 1.05% on a QoQ basis from $8.2 million in Q4 2025.
Glass House Brands (GLAS) Minority Interest (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Minority Interest data on file, last reported at $8.1 million in Q1 2026.
- On a quarterly basis, Minority Interest rose 118.76% year-over-year to $8.1 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 118.76% increase from a year earlier, with the FY2025 full-year figure at $8.2 million, up 121.19% from the prior year.
- Minority Interest for Q1 2026 stood at $8.1 million, down from $8.2 million in the prior quarter.
- Over the last five years, Minority Interest for GLAS reached as high as $15.0 million in Q4 2023 and fell as low as -$45.0 million in Q2 2025.
- Historically, Minority Interest has averaged -$12.5 million across 5 years, with a median of -$7.3 million in 2023.
- On a YoY basis, Minority Interest climbed as much as 451.99% in 2023 and fell as far as 3202.17% in 2023.
- Year by year, Minority Interest stood at -$4.3 million in 2022, then surged by 451.99% to $15.0 million in 2023, then sank by 356.96% to -$38.5 million in 2024, then jumped by 121.19% to $8.2 million in 2025, then slipped by 1.05% to $8.1 million in 2026.
- Per Business Quant data, the three most recent Minority Interest figures were $8.1 million in Q1 2026, $8.2 million in Q4 2025, and $7.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.08 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 7.88 Mn |
| Jun 30, 2025 | -45.00 Mn |
| Mar 31, 2025 | -43.07 Mn |
| Dec 31, 2024 | -38.54 Mn |
| Sep 30, 2024 | -34.07 Mn |
| Jun 30, 2024 | -30.18 Mn |
| Mar 31, 2024 | -26.38 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | -17.39 Mn |
| Jun 30, 2023 | -10.14 Mn |
| Mar 31, 2023 | -7.28 Mn |
| Dec 31, 2022 | -4.26 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | -220,370.00 |
| Dec 31, 2021 | -197,774.00 |
| Dec 31, 2020 | -1,168.00 |